Cargando…
Updates and new medical treatments for vitiligo (Review)
Vitiligo is a multifactorial disease characterized by the loss of skin pigment, which results in achromic macules and patches. There are currently several medical treatments available, which aim to arrest progression and induce skin repigmentation. These treatments alone or combined have exhibited v...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170669/ https://www.ncbi.nlm.nih.gov/pubmed/34093753 http://dx.doi.org/10.3892/etm.2021.10229 |
_version_ | 1783702291114622976 |
---|---|
author | Kubelis-López, David Emmanuel Zapata-Salazar, Natalia Aranza Said-Fernández, Salvador Luis Sánchez-Domínguez, Celia Nohemí Salinas-Santander, Mauricio Andrés Martínez-Rodríguez, Herminia Guadalupe Vázquez-Martínez, Osvaldo Tomás Wollina, Uwe Lotti, Torello Ocampo-Candiani, Jorge |
author_facet | Kubelis-López, David Emmanuel Zapata-Salazar, Natalia Aranza Said-Fernández, Salvador Luis Sánchez-Domínguez, Celia Nohemí Salinas-Santander, Mauricio Andrés Martínez-Rodríguez, Herminia Guadalupe Vázquez-Martínez, Osvaldo Tomás Wollina, Uwe Lotti, Torello Ocampo-Candiani, Jorge |
author_sort | Kubelis-López, David Emmanuel |
collection | PubMed |
description | Vitiligo is a multifactorial disease characterized by the loss of skin pigment, which results in achromic macules and patches. There are currently several medical treatments available, which aim to arrest progression and induce skin repigmentation. These treatments alone or combined have exhibited varying degrees of pigmentation, and the majority are safe and effective. All therapies for vitiligo are limited, and no known treatment can consistently produce repigmentation in all patients. Individualized treatment is appropriate according to the location, clinical presentation and the presence of disease activity. The present review summarizes the medical treatments available for vitiligo: Systemic and topic pharmacological therapies, physical and depigmentation treatments. Several treatments are still underway and have not yet been approved. However, due to the promising preliminary results, these are also mentioned in the present review. |
format | Online Article Text |
id | pubmed-8170669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-81706692021-06-04 Updates and new medical treatments for vitiligo (Review) Kubelis-López, David Emmanuel Zapata-Salazar, Natalia Aranza Said-Fernández, Salvador Luis Sánchez-Domínguez, Celia Nohemí Salinas-Santander, Mauricio Andrés Martínez-Rodríguez, Herminia Guadalupe Vázquez-Martínez, Osvaldo Tomás Wollina, Uwe Lotti, Torello Ocampo-Candiani, Jorge Exp Ther Med Review Vitiligo is a multifactorial disease characterized by the loss of skin pigment, which results in achromic macules and patches. There are currently several medical treatments available, which aim to arrest progression and induce skin repigmentation. These treatments alone or combined have exhibited varying degrees of pigmentation, and the majority are safe and effective. All therapies for vitiligo are limited, and no known treatment can consistently produce repigmentation in all patients. Individualized treatment is appropriate according to the location, clinical presentation and the presence of disease activity. The present review summarizes the medical treatments available for vitiligo: Systemic and topic pharmacological therapies, physical and depigmentation treatments. Several treatments are still underway and have not yet been approved. However, due to the promising preliminary results, these are also mentioned in the present review. D.A. Spandidos 2021-08 2021-05-25 /pmc/articles/PMC8170669/ /pubmed/34093753 http://dx.doi.org/10.3892/etm.2021.10229 Text en Copyright: © Kubelis-López et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Kubelis-López, David Emmanuel Zapata-Salazar, Natalia Aranza Said-Fernández, Salvador Luis Sánchez-Domínguez, Celia Nohemí Salinas-Santander, Mauricio Andrés Martínez-Rodríguez, Herminia Guadalupe Vázquez-Martínez, Osvaldo Tomás Wollina, Uwe Lotti, Torello Ocampo-Candiani, Jorge Updates and new medical treatments for vitiligo (Review) |
title | Updates and new medical treatments for vitiligo (Review) |
title_full | Updates and new medical treatments for vitiligo (Review) |
title_fullStr | Updates and new medical treatments for vitiligo (Review) |
title_full_unstemmed | Updates and new medical treatments for vitiligo (Review) |
title_short | Updates and new medical treatments for vitiligo (Review) |
title_sort | updates and new medical treatments for vitiligo (review) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170669/ https://www.ncbi.nlm.nih.gov/pubmed/34093753 http://dx.doi.org/10.3892/etm.2021.10229 |
work_keys_str_mv | AT kubelislopezdavidemmanuel updatesandnewmedicaltreatmentsforvitiligoreview AT zapatasalazarnataliaaranza updatesandnewmedicaltreatmentsforvitiligoreview AT saidfernandezsalvadorluis updatesandnewmedicaltreatmentsforvitiligoreview AT sanchezdominguezcelianohemi updatesandnewmedicaltreatmentsforvitiligoreview AT salinassantandermauricioandres updatesandnewmedicaltreatmentsforvitiligoreview AT martinezrodriguezherminiaguadalupe updatesandnewmedicaltreatmentsforvitiligoreview AT vazquezmartinezosvaldotomas updatesandnewmedicaltreatmentsforvitiligoreview AT wollinauwe updatesandnewmedicaltreatmentsforvitiligoreview AT lottitorello updatesandnewmedicaltreatmentsforvitiligoreview AT ocampocandianijorge updatesandnewmedicaltreatmentsforvitiligoreview |